compounded semaglutide not losing weight 5 Reasons You Aren't on Ozempic Not my most flattering photos.

Glucagon-like peptide-1 receptor agonists, or GLP-1 agonists , are a class of drugs that started as a diabetes treatment and then evolved into a popular weight loss tool

Plateaus, muscle loss, or shifts in appetite are normal, and staying flexible with your goals is key to long-term success

Many patients experience rapid initial loss (weeks 2-8), a plateau phase (weeks 8-16), then resumption of gradual loss as tolerance stabilizes

No published safety data for the combination

It is generally not seen for Tirzepatide or Retatrutide in standard metabolic research, as their long-acting nature makes daily administration unnecessary and potentially counterproductive due to accumulation

More water means a lower concentration, which means each unit on the syringe represents less semaglutide